These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 15747784)
1. Advances in understanding the biology and genetics of acute myelocytic leukemia. McKenzie SB Clin Lab Sci; 2005; 18(1):28-37. PubMed ID: 15747784 [TBL] [Abstract][Full Text] [Related]
2. Acute promyelocytic leukemia (AML-M3)--Part 2: Molecular defect, DNA diagnosis, and proposed models of leukemogenesis and differentiation therapy. Randolph TR Clin Lab Sci; 2000; 13(2):106-16. PubMed ID: 11066449 [TBL] [Abstract][Full Text] [Related]
3. New agents for the treatment of acute myeloid leukemia. Tallman MS Best Pract Res Clin Haematol; 2006; 19(2):311-20. PubMed ID: 16516128 [TBL] [Abstract][Full Text] [Related]
4. Immunophenotypic profile predictive of KIT activating mutations in AML1-ETO leukemia. De J; Zanjani R; Hibbard M; Davis BH Am J Clin Pathol; 2007 Oct; 128(4):550-7. PubMed ID: 17875504 [TBL] [Abstract][Full Text] [Related]
5. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia]. Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475 [TBL] [Abstract][Full Text] [Related]
6. Dominant and opportunistic leukemic clones: proposal for a pathogenesis-oriented classification in acute myeloid leukemia. Cucuianu A Med Hypotheses; 2005; 65(1):107-13. PubMed ID: 15893127 [TBL] [Abstract][Full Text] [Related]
7. Treatment of acute myeloid leukemia by directly targeting both leukemia stem cells and oncogenic molecule with specific scFv-immunolipoplexes as a deliverer. Wang GP; Qi ZH; Chen FP Med Hypotheses; 2008; 70(1):122-7. PubMed ID: 17566667 [TBL] [Abstract][Full Text] [Related]
8. [Pathobiology of acute myeloid leukemia]. Christ O; Feuring-Buske M; Hiddemann W; Buske C Med Klin (Munich); 2007 Apr; 102(4):290-5. PubMed ID: 17426932 [TBL] [Abstract][Full Text] [Related]
9. [Cytomorphology of acute mixed leukemia]. Sucić M; Batinić D; Zadro R; Mrsić S; Labar B Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415 [TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of a new human acute myelocytic leukemia cell line SH-2 with a loss of Y chromosome, a derivative chromosome 16 resulting from an unbalanced translocation between chromosomes 16 and 17, monosomy 17, trisomy 19, and p53 alteration. Qiu H; Xue Y; Zhang J; Pan J; Dai H; Wu Y; Wang Y; Chen S; Wu D Exp Hematol; 2008 Nov; 36(11):1487-95. PubMed ID: 18715689 [TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of CD7 in myeloblasts is highly associated with de novo acute myeloid leukemias with FLT3/ITD mutation. Rausei-Mills V; Chang KL; Gaal KK; Weiss LM; Huang Q Am J Clin Pathol; 2008 Apr; 129(4):624-9. PubMed ID: 18343790 [TBL] [Abstract][Full Text] [Related]
12. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia. Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229 [TBL] [Abstract][Full Text] [Related]
13. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells. Yan H; Peng ZG; Wu YL; Jiang Y; Yu Y; Huang Y; Zhu YS; Zhao Q; Chen GQ Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433 [TBL] [Abstract][Full Text] [Related]
14. Concurrent acute myeloid leukemia with inv(16)(p13.1q22) and chronic lymphocytic leukemia: molecular evidence of two separate diseases. Lu CM; Murata-Collins JL; Wang E; Siddiqi I; Lawrence H Am J Hematol; 2006 Dec; 81(12):963-8. PubMed ID: 16917916 [TBL] [Abstract][Full Text] [Related]
15. Therapy-related acute myeloid leukemia (t-AML) with poor-risk cytogenetics in two patients with persistent molecular complete remission of acute promyelocytic leukemia. Ojeda-Uribe M; Schneider A; Luquet I; Berceanu A; Cornillet-Lefebvre P; Jeandidier E; Lioure B; Ades L; Mauvieux L; Himberlin C Eur J Haematol; 2012 Sep; 89(3):267-72. PubMed ID: 22591288 [TBL] [Abstract][Full Text] [Related]
16. Acute myeloid leukemia in a child with hereditary thrombocytopenia. Rheingold SR Pediatr Blood Cancer; 2007 Jan; 48(1):105-7. PubMed ID: 16276527 [TBL] [Abstract][Full Text] [Related]
17. High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia. Lapillonne H; Renneville A; Auvrignon A; Flamant C; Blaise A; Perot C; Lai JL; Ballerini P; Mazingue F; Fasola S; Dehée A; Bellman F; Adam M; Labopin M; Douay L; Leverger G; Preudhomme C; Landman-Parker J J Clin Oncol; 2006 Apr; 24(10):1507-15. PubMed ID: 16575000 [TBL] [Abstract][Full Text] [Related]
18. The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia. Nagai S; Ichikawa M; Takahashi T; Sato H; Yokota H; Oshima K; Izutsu K; Hangaishi A; Kanda Y; Motokura T; Chiba S; Yatomi Y; Kurokawa M Exp Hematol; 2007 Nov; 35(11):1747-52. PubMed ID: 17976525 [TBL] [Abstract][Full Text] [Related]